Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue | 2 | 2026 | 182 | 1.710 |
Why?
|
| Muscle, Skeletal | 2 | 2026 | 316 | 1.580 |
Why?
|
| Antibodies, Protozoan | 5 | 2022 | 82 | 1.330 |
Why?
|
| Heel | 2 | 2026 | 2 | 1.230 |
Why?
|
| Plasmodium falciparum | 3 | 2022 | 144 | 1.000 |
Why?
|
| Nerve Compression Syndromes | 1 | 2025 | 2 | 0.940 |
Why?
|
| Muscular Atrophy | 1 | 2025 | 13 | 0.940 |
Why?
|
| Malaria, Falciparum | 4 | 2022 | 90 | 0.920 |
Why?
|
| Osteoarthritis | 2 | 2021 | 25 | 0.850 |
Why?
|
| Antigens, Protozoan | 4 | 2022 | 74 | 0.820 |
Why?
|
| Pain | 1 | 2026 | 290 | 0.780 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 263 | 0.770 |
Why?
|
| Pregnancy Complications, Parasitic | 2 | 2018 | 10 | 0.680 |
Why?
|
| Vitamin B 12 | 1 | 2021 | 23 | 0.680 |
Why?
|
| Coffee | 1 | 2021 | 20 | 0.680 |
Why?
|
| Drinking | 1 | 2021 | 37 | 0.680 |
Why?
|
| Folic Acid | 1 | 2021 | 49 | 0.680 |
Why?
|
| Nutrition Policy | 1 | 2021 | 64 | 0.660 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2021 | 58 | 0.650 |
Why?
|
| Eating | 1 | 2021 | 167 | 0.610 |
Why?
|
| Absenteeism | 1 | 2019 | 14 | 0.600 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 539 | 0.570 |
Why?
|
| Placenta | 2 | 2018 | 117 | 0.530 |
Why?
|
| Cross-Sectional Studies | 6 | 2026 | 3156 | 0.500 |
Why?
|
| Health Status | 1 | 2019 | 442 | 0.460 |
Why?
|
| Students | 1 | 2019 | 626 | 0.390 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2026 | 587 | 0.370 |
Why?
|
| Adult | 8 | 2026 | 13872 | 0.330 |
Why?
|
| Reproducibility of Results | 2 | 2026 | 1081 | 0.290 |
Why?
|
| Female | 9 | 2026 | 24698 | 0.290 |
Why?
|
| Humans | 15 | 2026 | 43102 | 0.280 |
Why?
|
| Middle Aged | 4 | 2026 | 12222 | 0.280 |
Why?
|
| Male | 8 | 2026 | 23409 | 0.270 |
Why?
|
| Young Adult | 5 | 2021 | 5080 | 0.250 |
Why?
|
| Retrospective Studies | 5 | 2025 | 2544 | 0.240 |
Why?
|
| Foot | 1 | 2025 | 10 | 0.240 |
Why?
|
| Case-Control Studies | 2 | 2026 | 1285 | 0.220 |
Why?
|
| Adolescent | 3 | 2021 | 6081 | 0.200 |
Why?
|
| Cameroon | 3 | 2018 | 35 | 0.200 |
Why?
|
| Prevalence | 2 | 2025 | 1612 | 0.200 |
Why?
|
| Aged | 3 | 2025 | 8214 | 0.180 |
Why?
|
| Malaria | 1 | 2022 | 90 | 0.180 |
Why?
|
| Parkinson Disease | 1 | 2024 | 210 | 0.180 |
Why?
|
| Sodium, Dietary | 1 | 2021 | 22 | 0.170 |
Why?
|
| Seafood | 1 | 2021 | 26 | 0.170 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2021 | 36 | 0.170 |
Why?
|
| Hospitalization | 1 | 2024 | 485 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 122 | 0.160 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2019 | 22 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 249 | 0.140 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 247 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 590 | 0.140 |
Why?
|
| Phenotype | 1 | 2021 | 780 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 102 | 0.140 |
Why?
|
| Family | 1 | 2019 | 195 | 0.130 |
Why?
|
| Age Factors | 1 | 2021 | 1154 | 0.130 |
Why?
|
| Pregnancy | 3 | 2018 | 1772 | 0.130 |
Why?
|
| Heart Failure | 1 | 2021 | 302 | 0.130 |
Why?
|
| Stroke | 1 | 2021 | 340 | 0.130 |
Why?
|
| Schools | 1 | 2019 | 283 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2021 | 925 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2017 | 195 | 0.120 |
Why?
|
| Antibody Affinity | 1 | 2015 | 21 | 0.120 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2015 | 2 | 0.110 |
Why?
|
| Asthma | 1 | 2019 | 416 | 0.110 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 44 | 0.110 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 1234 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 117 | 0.110 |
Why?
|
| Risk Factors | 2 | 2021 | 3994 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 2853 | 0.100 |
Why?
|
| Child | 2 | 2019 | 3443 | 0.100 |
Why?
|
| United States | 2 | 2021 | 5205 | 0.100 |
Why?
|
| Obesity | 1 | 2021 | 1151 | 0.090 |
Why?
|
| Kidney | 1 | 2015 | 372 | 0.090 |
Why?
|
| Merozoite Surface Protein 1 | 2 | 2022 | 34 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 259 | 0.080 |
Why?
|
| Immunization, Secondary | 1 | 2023 | 16 | 0.050 |
Why?
|
| Half-Life | 1 | 2023 | 63 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2022 | 76 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 127 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2022 | 86 | 0.050 |
Why?
|
| Social Isolation | 1 | 2022 | 34 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 306 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 355 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2024 | 1600 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 1175 | 0.040 |
Why?
|
| Merozoites | 1 | 2018 | 3 | 0.040 |
Why?
|
| Parasitemia | 1 | 2018 | 13 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 36 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 332 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 74 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2024 | 719 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 2018 | 191 | 0.030 |
Why?
|
| Placenta Diseases | 1 | 2015 | 5 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2015 | 34 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2015 | 30 | 0.030 |
Why?
|
| Hawaii | 1 | 2021 | 2011 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2015 | 135 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2015 | 1546 | 0.020 |
Why?
|